Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AKU Akumin		$0.18	$0.12 ▼ $1.90	$26.32M	-0.72	1.38 million shs	8.54 million shs
ANIX Anixa Biosciences	$3.05 +0.3%	$3.26	$2.07 ▼ $4.20	$97.92M	0.43	101,548 shs	72,682 shs
OPGN OpGen		$3.34	$0.00 ▼ $5.25	$1K	-1.66	8,778 shs	71 shs
QIPT Quipt Home Medical	$2.03 +2.5%	$2.01	$1.35 ▼ $3.35	$86.02M	0.59	298,556 shs	481,957 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AKU Akumin	0.00%	0.00%	0.00%	0.00%	0.00%
ANIX Anixa Biosciences	+3.40%	-3.49%	-3.18%	+19.22%	-4.70%
OPGN OpGen	0.00%	-99.75%	-100.00%	-100.00%	-100.00%
QIPT Quipt Home Medical	-6.60%	-12.78%	+5.88%	+27.74%	-36.54%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AKU Akumin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ANIX Anixa Biosciences	3.5021 of 5 stars	3.5	5.0	0.0	0.0	3.0	3.3	0.0
OPGN OpGen	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
QIPT Quipt Home Medical	3.0119 of 5 stars	3.3	5.0	0.0	0.0	2.2	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AKU Akumin	0.00	N/A	N/A	N/A
ANIX Anixa Biosciences	3.00	Buy	$9.00	195.08% Upside
OPGN OpGen	0.00	N/A	N/A	N/A
QIPT Quipt Home Medical	2.50	Moderate Buy	$2.85	40.39% Upside

Current Analyst Ratings Breakdown

Latest AKU, OPGN, ANIX, and QIPT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/5/2025	ANIX Anixa Biosciences	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00
6/10/2025	ANIX Anixa Biosciences	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00
5/29/2025	ANIX Anixa Biosciences	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00
5/14/2025	QIPT Quipt Home Medical	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$6.00 ➝ $4.00
5/13/2025	QIPT Quipt Home Medical	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$4.00 ➝ $1.70

(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AKU Akumin	$749.63M	0.00	N/A	N/A	$1.24 per share	0.00
ANIX Anixa Biosciences	$210K	467.81	N/A	N/A	$0.59 per share	5.17
OPGN OpGen	$2.67M	0.00	N/A	N/A	($11.55) per share	0.00
QIPT Quipt Home Medical	$245.91M	0.36	$1.04 per share	1.95	$2.36 per share	0.86

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AKU Akumin	-$156.76M	-$2.52	N/A	N/A	N/A	-30.56%	-167.86%	-7.81%	N/A
ANIX Anixa Biosciences	-$12.55M	-$0.38	N/A	∞	N/A	N/A	-68.17%	-60.38%	9/5/2025 (Estimated)
OPGN OpGen	-$32.67M	N/A	0.00	N/A	N/A	-1,140.36%	N/A	-287.58%	N/A
QIPT Quipt Home Medical	-$6.76M	-$0.21	N/A	N/A	N/A	-4.30%	-9.78%	-4.23%	N/A

Latest AKU, OPGN, ANIX, and QIPT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/5/2025	Q3 2025	ANIX Anixa Biosciences	-$0.10	N/A	N/A	N/A	N/A	N/A
8/11/2025	Q3 2025	QIPT Quipt Home Medical	$0.03	-$0.07	-$0.10	-$0.07	$80.37 million	$58.30 million
6/3/2025	Q2 2025	ANIX Anixa Biosciences	-$0.10	-$0.09	+$0.01	-$0.09	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AKU Akumin	N/A	N/A	N/A	N/A	N/A
ANIX Anixa Biosciences	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	N/A	N/A	N/A	N/A	N/A
QIPT Quipt Home Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AKU Akumin	17.02	0.99	0.99
ANIX Anixa Biosciences	N/A	8.89	8.89
OPGN OpGen	N/A	5.45	5.45
QIPT Quipt Home Medical	0.71	1.15	0.85

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AKU Akumin	36.10%
ANIX Anixa Biosciences	29.13%
OPGN OpGen	2.68%
QIPT Quipt Home Medical	42.85%

Insider Ownership

Company	Insider Ownership
AKU Akumin	20.51%
ANIX Anixa Biosciences	25.30%
OPGN OpGen	43.80%
QIPT Quipt Home Medical	13.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AKU Akumin	3,631	91.17 million	72.47 million	Not Optionable
ANIX Anixa Biosciences	5	32.21 million	24.06 million	Optionable
OPGN OpGen	100	10.07 million	4.70 million	Not Optionable
QIPT Quipt Home Medical	1,200	43.44 million	37.62 million	Optionable

AKU, OPGN, ANIX, and QIPT Headlines

Recent News About These Companies

Quipt Home Medical (NASDAQ:QIPT) Releases Earnings Results, Misses Estimates By $0.10 EPS

August 12 at 9:25 PM | marketbeat.com

Quipt Home Medical Corp. (QIPT) Q3 2025 Earnings Call Transcript

August 12 at 1:13 PM | seekingalpha.com

Quipt Home Medical Partners With Three Major Health Systems to Form Strategic Joint Venture

August 12 at 7:30 AM | globenewswire.com

Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

August 11 at 5:26 PM | financialpost.comF

Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

August 11 at 5:00 PM | globenewswire.com

Quipt Home Medical (QIPT) Projected to Post Earnings on Monday

August 10 at 3:41 AM | americanbankingnews.com

Quipt Home Medical (QIPT) to Release Quarterly Earnings on Monday

August 5, 2025 | marketbeat.com

Quipt Home Medical to Release Q3 2025 Financial Results

July 29, 2025 | tipranks.com

Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025

July 29, 2025 | financialpost.comF

Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025

July 29, 2025 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

July 27, 2025 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

July 22, 2025 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

July 17, 2025 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

July 12, 2025 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

July 10, 2025 | globenewswire.com

Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 ... - Morningstar

July 8, 2025 | morningstar.comM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

July 7, 2025 | prnewswire.com

Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 ...

July 7, 2025 | bakersfield.comB

Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States

July 7, 2025 | financialpost.comF

Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States

July 7, 2025 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

July 6, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AKU, OPGN, ANIX, and QIPT Company Descriptions

Akumin NASDAQ:AKU

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

Anixa Biosciences NASDAQ:ANIX

$3.05 +0.01 (+0.33%)

Closing price 04:00 PM Eastern

Extended Trading

$2.98 -0.07 (-2.43%)

As of 07:56 PM Eastern

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

OpGen NASDAQ:OPGN

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

Quipt Home Medical NASDAQ:QIPT

$2.03 +0.05 (+2.53%)

Closing price 04:00 PM Eastern

Extended Trading

$2.04 +0.01 (+0.49%)

As of 05:49 PM Eastern

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time